<DOC>
	<DOC>NCT00425997</DOC>
	<brief_summary>This study will evaluate the efficacy of valsartan/hydrochlorothiazide versus amlodipine and hydrochlorothiazide in patients with Stage 2 hypertension using 24-hr ambulatory blood pressure monitoring (ABPM)</brief_summary>
	<brief_title>Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male or female patients 18 years of age or older Diagnosed of having hypertension, defined as a mean seated systolic BP â‰¥160 mmHg (Stage 2 hypertension) Symptomatic or severe hypertension Patients treated with more than 2 antihypertensive medications Clinically known or suspected history of secondary hypertension Myocardial infarction, stroke, transient ischemic attack, cardiovascular revascularization/angioplasty in last 6 months Diagnosis of heart failure (NYHA Class IIIV) Chronic renal or severe hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Hypertension, valsartan/HCTZ, amlodipine and HCTZ</keyword>
</DOC>